GABAPENTIN

Product NDC: 43602-471
11-digit product format: 436020471
Labeler code: 43602
Product ID: 43602-471_f2b29432-5b8e-4cd0-93f6-5dd626087eb4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: Ascent Pharmaceuticals, Inc
Application: ANDA214956
Marketing category: ANDA
Marketing start: 2021-05-10
Marketing end: 0000-00-00
Substance: GABAPENTIN
Active strength: 400 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	43602-471		D	Discontinued by firm	2026-08-17
excluded package	package	43602-471	43602-471-05	D	Discontinued by firm	2026-08-17
excluded package	package	43602-471	43602-471-30	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product	43602-471		D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43602-471	43602-471-05	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43602-471	43602-471-30	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A214956-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10
A214956-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10
A214956-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A214956-001	AB
A214956-002	AB
A214956-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 102 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 102 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A214956-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A214956-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214956-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A214956-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-001	AB	1	`1e350fbaab3a…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
43602-471	GABAPENTIN CAPSULE [ASCENT PHARMACEUTICALS, INC]	3	Legacy NDC	20210514_433fbf5e-7b32-4c8b-8c89-ef39ce1bee7d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GABAPENTIN	GABAPENTIN	St. Mary's Medical Park Pharmacy	235a6954-318a-9e3a-e063-6394a90a0e21	2026-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Preferred Pharmaceuticals Inc.	dd0e12c2-1986-4ca3-a809-d703a7542419	2026-04-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	4aa69d04-6b32-4764-a48b-ef5313dd95d3	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	43a3ec78-8235-4d46-a343-2f9226745a39	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	685553b0-384e-400b-a8ae-612ceece8261	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	7ea0b220-edbb-45eb-aeb3-65283f8489a1	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Northwind Health Company, LLC	47214c7c-ba1b-9107-e063-6294a90a5431	2025-12-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Redpharm Drug	44f2b497-55b2-864f-e063-6294a90ad6d5	2025-12-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	REMEDYREPACK INC.	fbeccab7-08aa-4da3-868f-b47a1f3d41ef	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	XLCare Pharmaceuticals, Inc.	618c948d-deee-44e2-98f0-e5232171dd50	2025-08-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	NuCare Pharmaceuticals, Inc.	200b61d7-6e4c-923d-e063-6294a90a42cf	2025-02-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Bryant Ranch Prepack	35ac6b11-7b1c-47a0-a4ba-c193a0bb5b01	2025-02-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	NuCare Pharmaceuticals,Inc.	2b395a14-0f8e-7f5b-e063-6294a90ab546	2025-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Camber Pharmaceuticals, Inc.	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	2024-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Asclemed USA, Inc.	17a62334-209d-4dc1-867a-e5780196a2ca	2024-11-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	2024-01-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
43602-471-05	43602047105	500 CAPSULE in 1 BOTTLE (43602-471-05)	500 capsule	2021-05-10	0000-00-00	No	No	Current
43602-471-30	43602047130	30 CAPSULE in 1 BOTTLE (43602-471-30)	30 capsule	2021-05-10	0000-00-00	No	No	Current